CN
Magen contact QR code.png
banner
Tu ubicación actual:Inicio/Empresa/Noticias/Marketing/Research progress on SARS-CoV-2

Research progress on SARS-CoV-2

Fecha de lanzamiento:2021-12-09

Neurological complications and infection mechanism of SARS-CoV-2

Abstract

Currently, SARS-CoV-2 has caused a global pandemic and threatened many lives. Although SARS-CoV-2 mainly causes respiratory diseases, growing data indicate that SARS-CoV-2 can also invade the central nervous system (CNS) and peripheral nervous system (PNS) causing multiple neurological diseases, such as encephalitis, encephalopathy, Guillain-Barré syndrome, meningitis, and skeletal muscular symptoms. Despite the increasing incidences of clinical neurological complications of SARS-CoV-2, the precise neuroinvasion mechanisms of SARS-CoV-2 have not been fully established. In this review, we primarily describe the clinical neurological complications associated with SARS-CoV-2 and discuss the potential mechanisms through which SARS-CoV-2 invades the brain based on the current evidence. Finally, we summarize the experimental models were used to study SARS-CoV-2 neuroinvasion. These data form the basis for studies on the significance of SARS-CoV-2 infection in the brain.

For details, please visit https://www.nature.com/articles/s41392-021-00818-7


Magen is paying her effort to help the resistance of new virus and has devleoped a complete solution for virus nucleic acid extration, including DNA/RNA extraction kits, raw materials and automated extraction machines.

For details please visit: http://www.magen-tec.com/technicalsolutions/info.aspx?itemid=391&lcid=132


May mankind stay away from disease.
Volver a la lista
Envíenos un mensaje

Envíenos un mensaje

    Por favor, proporciónenos la información a continuación y nos pondremos en contacto con usted lo antes posible.

This site uses cookies to improve your online experience,allow you to share content on social media,measure traffic to this website and display customised ads based on your browsing activity.